ramosetron: Clinical Trials

9 trials of ramosetron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 active not recruiting. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 6, Unknown 2, Active not recruiting 1
Phase 21Active not recruiting 1

Follow ramosetron: new trials by email Literature Review of ramosetron trials Research Report on ramosetron

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence
Ramosetron, Psyllium - Fecal Incontinence
Phase 2 / Phase 3Active not recruitingSeoul National University Hospital1472024-01-192026-10-27
Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting
ramosetron, Ondansetron - Postoperative Nausea and Vomiting
Phase 3CompletedThammasat University992014-04-012016-07-13
Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
Ramosetron - Uterine Myoma, Ovary Neoplasm, Adenomyosis
Phase 3UnknownNational Health Insurance Service Ilsan Hospital1282013-11-012013-12-13
A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
YM060, Placebo - Diarrhea-predominant Irritable Bowel Syndrome
Phase 3CompletedAstellas Pharma Inc5772013-02-012015-10-12
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
YM060 - Diarrhea-predominant Irritable Bowel Syndrome
Phase 3CompletedAstellas Pharma Inc1512012-09-012015-10-12
Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
ramosetron, ondansetron - Cancer, Malignancy
Phase 3UnknownHallym University Medical Center3382011-06-012012-10-03
Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
ramosetron, ondansetron - Radiotherapy Induced Nausea and Vomiting
Phase 3CompletedSeoul National University Hospital1722009-09-012011-02-28
A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea
Ramosetron, Granisetron - Vomiting, Nausea
Phase 3CompletedAstellas Pharma Inc2872006-01-012017-03-09
Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
YM060 - Irritable Bowel Syndrome
Phase 3CompletedAstellas Pharma Inc2015-10-12

Conditions studied

Vomiting (4)  ·  Postoperative Nausea and Vomiting (2)  ·  Adenomyosis (1)  ·  Diarrhea (1)  ·  Fecal Incontinence (1)  ·  Irritable Bowel Syndrome (1)  ·  Myofibroma (1)  ·  Nausea (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)

Sponsors

Astellas Pharma Inc (4)  ·  Seoul National University Hospital (2)  ·  Hallym University Medical Center (1)  ·  National Health Insurance Service Ilsan Hospital (1)  ·  Thammasat University (1)

Countries

South Korea (4)  ·  Japan (3)  ·  Taiwan (1)

Top investigators

Rumi Shin, MD, PhD (1)  ·  Sangwon Shin, M.D. (1)

Results publications

PMID 26551550, PMID 26800997, PMID 31538078